Distance Learning

New Hazardous Waste Pharmaceuticals Rule: Significant Changes Coming for Health Care Facilities, Particularly Long Term Care Facilities - On Demand Recording

Recorded On: 06/04/2019

Time: 90 minutes
Session Format: On Demand Recording
CLE Credit Available:  No

For on-demand webinar recordings, streaming access is available for 12-months from the date of the live webinar.  After 12-months, on-demand webinar recordings are available through the AHLA Health Law Archive.

Understanding EPA’s New Management Standards for Hazardous Waste Pharmaceuticals:  What Health Care Providers Need to Know (and Do)

In an effort to better align the Resource Conservation and Recovery Act (RCRA) standards for hazardous waste with the practical realities of how hazardous waste pharmaceuticals are managed in the health care facility setting, the U.S. Environmental Protection Agency recently promulgated a final rule that establishes a completely new set of management standards for hazardous waste pharmaceuticals in health care facilities. The rule also prohibits the sewering of hazardous waste pharmaceuticals and deletes the hazardous waste listing for certain nicotine replacement therapies.  
The rule applies to a broad array of health care facilities, including hospitals, long-term care facilities, pharmacies, reverse distributors, and others.  While the new requirements present a compliance challenge for all health care facilities covered by the rule, long-term care facilities will face the greatest challenge as they, for the first time, will be required to manage not only their hazardous waste pharmaceuticals, but also their non-pharmaceutical hazardous waste, in accordance with RCRA requirements.
Join your colleagues for an engaging discussion of the requirements of the EPA Hazardous Waste Pharmaceuticals Rule and what the rule means for health care facilities in general, but especially for long-term care facilities.


Level of Difficulty: Intermediate

  • AHLA Member: $99
  • Non-AHLA Member: $149

Content Lead:

  • Post-Acute and Long Term Services Practice Group

Jennifer Hilliard

Attorney

Arnall Golden Gregory, LLP
Washington, DC
Bio

Ralph DeMeo

Shareholder

Baker Donelson
Tallahassee, FL
Bio